Form 8-K - Current report:
SEC Accession No. 0001193125-25-262576
Filing Date
2025-11-03
Accepted
2025-11-03 16:15:31
Documents
15
Period of Report
2025-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d21938d8k.htm   iXBRL 8-K 27313
2 EX-99.1 d21938dex991.htm EX-99.1 121725
7 GRAPHIC g21938page1.jpg GRAPHIC 4360
  Complete submission text file 0001193125-25-262576.txt   325096

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20251103.xsd EX-101.SCH 4246
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20251103_def.xml EX-101.DEF 13884
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20251103_lab.xml EX-101.LAB 23295
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20251103_pre.xml EX-101.PRE 14852
17 EXTRACTED XBRL INSTANCE DOCUMENT d21938d8k_htm.xml XML 6202
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 251444288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)